Showing results (41-50 of 530) with videos related to
Sort By:
Pageof 53
Journal of Aerosol Medicine and Pulmonary Drug Delivery|August 4, 2012
Regulatory aspects of Phase 3 endpoints for new inhaled antibiotics for cystic fibrosis patients with chronic Pseudomonas aeruginosa infectionsAlan Bruce Montgomery, Tammy Abuan, Melissa A YeagerClinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 2018
AR-Variant-Positive CTC: A Surrogate for a Surrogate for Taxane Therapy Outcome?Scott M Dehm, Bruce Montgomery, Stephen R PlymateEndocrinology|August 23, 2014
Minireview: SLCO and ABC transporters: a role for steroid transport in prostate cancer progressionEunpi Cho, R Bruce Montgomery, Elahe A MostaghelClinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2013
Molecular pathways: targeting resistance in the androgen receptor for therapeutic benefitElahe A Mostaghel, Stephen R Plymate, Bruce MontgomeryPlos One|September 30, 2020
Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancerAlexander S Carlson, Rigo I Acevedo, Daniel M Lim, et al.European Urology Oncology|May 24, 2025
Results from a Phase 2 Study of Induction Docetaxel and Carboplatin Followed by Maintenance Rucaparib in the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer with DNA Homologous Recombination Repair DeficiencyRuben Raychaudhuri, Heather H Cheng, Roman Gulati, et al.BMC Molecular Biology|February 19, 2013
Single cell transcriptomic analysis of prostate cancer cellsChristopher J Welty, Ilsa Coleman, Roger Coleman, et al.Journal for Immunotherapy of Cancer|April 19, 2018
Microsatellite instability in prostate cancer by PCR or next-generation sequencingJennifer A Hempelmann, Christina M Lockwood, Eric Q Konnick, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 28, 2012
Cellular senescence and cancer chemotherapy resistanceRyan R Gordon, Peter S NelsonPageof 53